bcbs coverage for glp 1 GLP-1 BCBS Michigan obesity coverage update!🚨,

These engaging gatherings serve as a space to highlight successes, exchange best practice and explore opportunities to share strategies that help combat common challenges

Heres perspective: In 2019, providers wrote 1.3 million prescriptions for GLP-1s to adults in the U.S

Factors that could lead to discontinuation include side effects, plateauing results, and readiness for lifestyle changes

This allows the medication to disperse into the tissue and reduces leakage

The Endocrine Society's 2015 obesity pharmacotherapy guidelines recommend that "dose escalation be delayed for patients experiencing intolerable adverse events." This applies directly to GLP-1 agents and gives prescribers explicit guideline backing to slow the titration schedule when needed [12]